<DOC>
	<DOCNO>NCT01626443</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) one common endocrine disorder woman reproductive age characterize menstrual abnormality , clinical biochemical hyperandrogenism , multiple abnormal cyst enlarge ovary . Women affect PCOS often suffer insulin resistance compensatory hyperinsulinemia put risk develop several metabolic disorder . Inositol six-carbon polyol characterize insulin sensitizer : exists nine different isomer among myo-inositol D-chiroinositol represent studied physiology physiopathology . In particular , myo-inositol ( MI ) D-chiro inositol ( DCI ) glycans administration report exert beneficial effect metabolic , hormonal ovarian level . The aim randomize study evaluate metabolic ovaric effect six-month supplementation myo-inositol D-chiro-inositol young woman PCOS hyperinsulemia .</brief_summary>
	<brief_title>Role Myo-inositol D-chiro Inositol Ovaric Metabolic Functions</brief_title>
	<detailed_description />
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>PCOS Women age 1440 year BMI &gt; 28 Hyperinsulinemia Preexisting secondary endocrine metabolic disorder Preexisting secondary adrenal disorder Pharmacologic treatment last 3 month enter study Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PCOS</keyword>
	<keyword>Metabolic disorder</keyword>
	<keyword>Ovarian functionality</keyword>
	<keyword>Myo-inositol</keyword>
	<keyword>D-chiro-inositol</keyword>
</DOC>